The S447X polymorphism of the lipoprotein lipase gene is associated with lipoprotein lipid and blood pressure levels in Chinese patients with essential hypertension

被引:18
|
作者
Liu, AP
Lee, LM [1 ]
Zhan, SY
Cao, WH
Lv, J
Guo, XX
Hu, YH
机构
[1] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100083, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
基金
美国国家科学基金会;
关键词
lipoprotein lipase; polymorphism; dyslipidemia; essential hypertension;
D O I
10.1097/01.hjh.0000125456.28861.e4
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To investigate the association between the S447X polymorphism of the lipoprotein lipase (LPL) gene and lipoprotein lipid and blood pressure (BP) levels in 904 Chinese subjects with essential hypertension. Method Five hundred and sixty-three male and 341 female patients (aged 35-69 years) were randomly selected from hypertensive patients diagnosed in the Community-based Comprehensive Studies on Prevention and Control of Hypertension Project in China (CCPACH) and not treated with anti hypertensive medications for at least 2 weeks immediately before blood collection. Results After multivariate adjustment for age, body mass index (BMI), smoking status, alcohol intake and serum glucose, the X447 allele was significantly associated with low triglyceride, log triglyceride: high-density lipoprotein (HDL)-cholesterol ratio and high HDL-cholesterol levels compared with the S447S genotype, but not with BP levels in the whole study population. However, upon stratification for dyslipidemic status, the X447 allele was associated with higher systolic blood pressure (SBP) (P<0.05) and pulse pressure (PP) (P<0.05) compared with the S447S genotype after multivariate adjustment in dyslipidemic subjects, but not in those without dyslipidemia. A statistically significant interaction between the LPL S447X polymorphism and dyslipidemic status was observed for SBP and PP levels, suggesting that dyslipidemic status might modify the effect of the LPL S447X polymorphism on BP levels. Conclusions Our findings suggest that a high concentration of triglyceride and/or low concentration of HDL-cholesterol are associated with high SBP and PP in hypertensive patients with the X447 allele of the LPL gene.
引用
收藏
页码:1503 / 1509
页数:7
相关论文
共 50 条
  • [21] The lipoprotein lipase S447X polymorphism and plasma lipids:: interactions with APOE polymorphisms, smoking, and alcohol consumption
    Lee, J
    Tan, CS
    Chia, KS
    Tan, CE
    Chew, SK
    Ordovas, CJM
    Tai, ES
    JOURNAL OF LIPID RESEARCH, 2004, 45 (06) : 1132 - 1139
  • [22] Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study
    A Q Huang
    Y H Hu
    S Y Zhan
    B Xu
    Z C Pang
    W H Cao
    J Lu
    Y Qin
    L M Lee
    International Journal of Obesity, 2006, 30 : 1693 - 1701
  • [23] Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
    Wood, Alexis C.
    Glasser, Stephen
    Garvey, W. Timothy
    Kabagambe, Edmond K.
    Borecki, Ingrid B.
    Tiwari, Hemant K.
    Tsai, Michael Y.
    Hopkins, Paul N.
    Ordovas, Jose M.
    Arnett, Donna K.
    LIPIDS IN HEALTH AND DISEASE, 2011, 10
  • [24] Lipoprotein lipase S447X - A naturally occurring gain-of-function mutation
    Rip, Jaap
    Nierman, Melchior C.
    Ross, Colin J.
    Jukema, Jan Wouter
    Hayden, Michael R.
    Kastelein, John J. P.
    Stroes, Erik S. G.
    Kuivenhoven, Jan Albert
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (06) : 1236 - 1245
  • [25] Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
    Alexis C Wood
    Stephen Glasser
    W Timothy Garvey
    Edmond K Kabagambe
    Ingrid B Borecki
    Hemant K Tiwari
    Michael Y Tsai
    Paul N Hopkins
    Jose M Ordovas
    Donna K Arnett
    Lipids in Health and Disease, 10
  • [26] Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation
    Ross, Colin J. D.
    Twisk, Jaap
    Bakker, Andrew C.
    Miao, Fudan
    Verbart, Dennis
    Rip, Jaap
    Godbey, Tamara
    Dijkhuizen, Paul
    Hermens, Wim T. J. M. C.
    Kastelein, John J. P.
    Kuivenhoven, Jan Albert
    Meulenberg, Janneke M.
    Hayden, Michael R.
    HUMAN GENE THERAPY, 2006, 17 (05) : 487 - 499
  • [27] Enhanced APOB48 metabolism in lipoprotein lipase S447X carriers
    Nierman, M. C.
    Rip, J.
    Kuivenhoven, J. A.
    Sakai, N.
    Kastelein, J. J. P.
    De Sain-Van Der Velden, M. G. M.
    Stroes, E. S. G.
    Prinsen, B. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 134 - 134
  • [28] Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort
    Sass, G
    Herbeth, B
    Siest, G
    Visvikis, S
    JOURNAL OF HYPERTENSION, 2000, 18 (12) : 1775 - 1781
  • [29] Gain-of-function mutations and therapeutic implications - Lipoprotein lipase S447X to the rescue
    Rader, DJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) : 2018 - 2019
  • [30] Response to pioglitazone treatment is associated with the lipoprotein lipase S447X variant in subjects with type 2 diabetes mellitus
    Wang, G.
    Wang, X.
    Zhang, Q.
    Ma, Z.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (04) : 552 - 557